{"SPADE_N_03024": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 8202835 B2", "Patent Link": "http://www.lens.org/lens/patent/US_8202835_B2", "Patent Type": "Granted Patent", "Publication Date": "2012-6-19", "Family Info": "US8426366,US20090048167,US20120277157", "Patent Title": "Disease treatment via antimicrobial peptides or their inhibitors.", "Abstract": "The invention provides methods for the treatment of disease and promotion of healing that include providing a therapeutically effective amount of a mammalian antimicrobial peptide (AMP) or analog thereof, in particular a cathelicidin or cathelicidin fragment or cathelicidin analog, thereby treating the disease in the subject in need thereof. The invention also provides specific analogs or fragments of cathelicidin that function as agonists, as do endogenous cathelicidins, or as either dominant negatives or as inhibitors to endogenous cathelicidin or to other endogenous AMPs or that compete with pro-inflammatory agents or fragments of AMPs on cognate receptors without inducing disease."}], "Sequence Information": {"SPADE ID": "SPADE_N_03024", "Peptide Name": "rCRAMP (rat cathelin-related antimicrobial peptide; Rodents, mammals, animals)", "Source": "Rattus norvegicus (Norway rat)", "Family": "Not found", "Gene": "Not found", "Sequence": "GLVRKGGEKFGEKLRKIGQKIKEFFQKLALEIEQ", "Sequence Length": 34, "UniProt Entry": "No entry found", "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Antibacterial"], "Target Organism": "[No NaCl]:Escherichia coli DH5a (MIC=0.54 µM), E. coli ML-35p (MIC=1.55 µM), Pseudomonas aeruginosa PAO1 (MIC=0.69 µM), Pseudomonas aeruginosa MR3007 (MIC=2.01 µM); Staphylococcus aureus ATCC (MRSA) 33591 (MIC=3.19 µM), Staphylococcus aureus 93918 (MIC=2.14 µM).[100 mM NaCl]:Escherichia coli DH5a (MIC=0.61 µM), Escherichia coli ML-35p (MIC=0.66 µM), Pseudomonas aeruginosa PAO1 (MIC=1.17 µM), Pseudomonas aeruginosa MR3007 (MIC=1.78 µM), Staphylococcus aureus ATCC (MRSA) 33591 (MIC>20.1 µM), Staphylococcus aureus 93918 (MIC=2.16 µM).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C181H302N50O48", "Mass": 3946.64, "PI": 9.87, "Net Charge": 4, "Hydrophobicity": -0.68, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Function": "Has antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.", "Literature": [{"Title": "Bactericidal activity of mammalian cathelicidin-derived peptides.", "Pubmed ID": "10768969", "Reference": "Infect Immun. 2000 May;68(5)2748-2755.", "Author": "Travis SM, Anderson NN, Forsyth WR, Espiritu C, Conway BD, Greenberg EP, McCray PB Jr, Lehrer RI, Welsh MJ, Tack BF.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=10768969"}], "Frequent Amino Acids": "KEG", "Absent Amino Acids": "CDHMNOPSTUWY", "Basic Residues": 9, "Acidic Residues": 5, "Hydrophobic Residues": 12, "Polar Residues": 14, "Positive Residues": 9, "Negative Residues": 5, "Similar Sequences": [{"SPADE_ID": "SPADE_N_08844", "Similarity": 1.0, "Sequence": "ISRLAGLVRKGGEKFGEKLRKIGQKIKEFFQKLALEIEQ"}, {"SPADE_ID": "SPADE_UN_25196", "Similarity": 1.0, "Sequence": "ISRLAGLVRKGGEKFGEKLRKIGQKIKEFFQKLALEIEQ"}, {"SPADE_ID": "SPADE_N_02965", "Similarity": 0.8888888888888888, "Sequence": "GEKLKKIGQKIKNFFQKL"}]}}}